TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
SLS

Sellas Life Sciences Group Inc

Healthcare · Biotechnology · —

11.60$ -3.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement SLS
Line item 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – 0.00 108.76 91.93 260.23 0.00 0.00 0.00 0.00 0.00 0.00 0.49 0.05 0.00 0.00 0.00
– 3,005.00 – – – 14.96 2.62 19.22 39.18 17.75 0.01 0.00 0.00 – 0.05 0.01 0.01 0.00 – –
– -3,005.00 – – – -1,907.24 108.76 72.71 221.05 -17.75 -0.01 0.00 0.00 – 0.00 0.48 0.05 0.00 – –
343.39 1,776.46 1,711.31 1,829.63 1,429.38 1,058.63 779.91 779.03 791.77 1,180.55 59.83 129.62 70.03 3.95 1.16 1.38 1.56 0.86 0.31 0.15
– 983.41 1,182.44 1,128.19 1,588.96 629.69 351.42 539.66 875.26 530.45 36.17 322.37 48.83 3.88 1.20 0.73 0.65 0.50 0.20 0.11
636.24 3,005.00 3,530.57 3,604.94 2,987.11 1,907.24 1,131.34 1,323.54 1,679.32 1,693.25 96.00 451.98 120.78 7.83 -2.37 2.11 2.21 1.36 0.51 0.26
-636.24 -3,005.00 -3,530.57 -3,604.94 -3,018.34 -1,907.24 -1,131.34 -1,250.83 -1,022.20 -1,711.00 -48.16 -335.72 -120.78 -7.83 -2.13 -1.63 -2.16 -1.36 -0.51 -0.26
0.00 0.00 0.00 1.03 0.91 0.00 1.76 29.83 31.00 38.00 10.57 9.87 1.02 0.05 0.05 0.28 0.03 – – –
-636.24 -2,887.05 -3,486.90 -3,783.33 -2,177.38 -1,053.77 -1,834.61 -2,795.37 -1,022.20 -1,929.55 -53.26 -502.08 -111.06 -7.57 -2.10 -1.35 -2.13 -1.34 -0.50 -0.25
– 6.58 – 178.40 -840.96 -853.47 -56.14 38.89 -431.32 18.25 0.73 5.41 -5.27 -0.03 0.00 -0.02 -0.03 -1.36 – –
-636.24 -2,893.63 -3,486.90 -3,783.33 -2,177.38 -1,053.77 -1,866.21 -2,834.26 -1,022.20 -3,195.10 -70.94 -507.49 -105.80 -7.54 -2.10 -1.34 -2.13 -1.34 -0.50 -0.25
-636.24 -2,877.57 -3,455.12 -3,748.97 -2,146.15 -1,038.81 -1,128.72 281.95 -1,022.20 -1,873.80 -48.15 -492.21 -127.69 0.26 3.33 -1.18 -1.62 0.02 0.01 -0.25

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?